Screener / SEC EDGAR /CIK 0001745999 /10-K filed Feb 24, 2026, compared with Feb 25, 2025 /Numbers from the XBRL of the 10-Ks
Nasdaq Health care · Biotechnology

Beam Therapeutics Inc. BEAM

Compare with peers Embed
Planned sales, announced before they happen

4 trading plans running, 17 Form 144 notices for $13.4M

10-Q, 10-K and Form 144
Plans running now 4 Bethany Cavanagh, John Evans, Amy Simon, Christine Bellon
Plans adopted 18 reported since May 10, 2023 Form 144 notices 17 $13.4M the sellers expected to sell

What BEAM's directors and officers said they would sell, before they sold: trading plans the company reports each quarter, and the Form 144 notices sellers file on the day of a planned sale. Most of these sales are routine, such as selling shares from vesting stock awards.

Plans adopted or ended

Trading plans · XBRL, 10-Q and 10-K

From Nov 7, 2024 to Sep 17, 2027. The thin line is today; a filled bar is a plan still running, a paler one has ended or expired. The ten newest plans are drawn; all are in the table.

InsiderWhatDateReported in
Bethany Cavanagh
Senior Vice President, Finance
Adopted 10b5-1 plan Sep 17, 2026 10-Q Nov 3, 2026
John Evans
Chief Executive Officer
Adopted 10b5-1 plan Jun 16, 2026 10-Q Aug 4, 2026
Amy Simon
Chief Medical Officer
Adopted 10b5-1 plan Mar 27, 2026 10-Q May 7, 2026
Christine Bellon
Chief Legal Officer
Adopted 10b5-1 plan Mar 27, 2026 10-Q May 7, 2026
Giuseppe Ciaramella
President
Adopted 10b5-1 plan Sep 30, 2025 10-Q Nov 4, 2025
Bethany Cavanagh
Senior Vice President, Finance
Adopted 10b5-1 plan Sep 19, 2025 10-Q Nov 4, 2025
Christine Bellon
Chief Legal Officer
Adopted 10b5-1 plan Sep 16, 2025 10-Q Nov 4, 2025
Sravan K. Emany
Chief Financial Officer
Adopted 10b5-1 plan Aug 11, 2025 10-K Feb 24, 2026
John Evans
Chief Executive Officer
Adopted 10b5-1 plan May 16, 2025 10-Q Aug 5, 2025
Amy Simon
Chief Medical Officer
Adopted 10b5-1 plan Nov 7, 2024 10-K Feb 25, 2025
Giuseppe Ciaramella
President
Adopted 10b5-1 plan Sep 26, 2024 10-Q Nov 5, 2024
Christine Bellon
Chief Legal Officer
Adopted 10b5-1 plan Sep 20, 2024 10-Q Nov 5, 2024
Bethany Cavanagh
Senior Vice President, Finance
Adopted 10b5-1 plan Aug 9, 2024 10-Q Nov 5, 2024
Giuseppe Ciaramella
President
Adopted 10b5-1 plan Jun 28, 2024 10-Q Aug 6, 2024
John Evans
Chief Executive Officer
Adopted 10b5-1 plan Jun 14, 2024 10-Q Aug 6, 2024
Giuseppe Ciaramella
President
Adopted 10b5-1 plan Dec 20, 2023 10-K Feb 27, 2024
Christine Bellon
Chief Legal Officer
Adopted 10b5-1 plan Dec 12, 2023 10-K Feb 27, 2024
Terry-Ann Burrell
Chief Financial Officer
Adopted 10b5-1 plan Dec 8, 2023 10-K Feb 27, 2024
Show the other 10 plans

From the XBRL of the company's 10-Qs and 10-Ks (Regulation S-K Item 408, reported since 2023): 15 filings checked since May 10, 2023.

Notices of planned sales

Form 144 · Form 144 XML, SEC

What the sellers expected to sell on the Form 144 notices filed each month (the value on the notice).

FiledSellerSharesValue
Oct 16, 2026 JOHN M EVANS
Officer, Director
25,000 $600K
Oct 15, 2026 JOHN M EVANS
Officer, Director
25,000 $589K
Jul 27, 2026 AMY SIMON
Officer
16,677 $429K
Jun 30, 2026 JOHN M EVANS
Officer, Director
25,000 $858K
Jun 29, 2026 JOHN M EVANS
Officer, Director
25,000 $887K
Apr 14, 2026 CAROLE HO
Director
87,784 $2.7M
Mar 31, 2026 JOHN M EVANS
Officer, Director
25,000 $569K
Mar 31, 2026 CHRISTINE BELLON
Officer
20,000 $438K
Mar 31, 2026 GIUSEPPE CIARAMELLA
Officer
26,250 $575K
Mar 31, 2026 AMY SIMON
Officer
20,000 $438K
Mar 31, 2026 JOHN M. EVANS
Officer, Director
66,874 $1.5M
Mar 30, 2026 JOHN M EVANS
Officer, Director
25,000 $559K
Feb 24, 2026 GIUSEPPE CIARAMELLA
Officer
35,000 $1.1M
Jan 30, 2026 JOHN M EVANS
Officer, Director
25,000 $709K
Jan 29, 2026 JOHN M EVANS
Officer, Director
25,000 $735K
Jan 22, 2026 CHRISTINE BELLON
Officer
1,371 $47K
Jan 15, 2026 CHRISTINE BELLON
Officer
18,629 $645K
Show the other 9 notices

From the Form 144 XML filed with the SEC, since Jan 15, 2026. The value is the seller's estimate on the notice. "Form 4 sales after" matches the seller's Form 4 sales in the 30 days after the notice, by name; Form 4s go back 180 days.

Sources

Regulation S-K Item 408 in the XBRL of each 10-Q and 10-K (since 2023); the Form 144 XML at the SEC.

Also

Insider trades: the Form 4s for the sales these plans led to.

Work with it

Excel workbook · CSV. Google Sheet that stays up to date: paste =IMPORTDATA("https://tickdelta.com/company/BEAM/export.csv") into a cell.

Next:Owners
Esc

Type a ticker such as AAPL, a name, an investor such as Buffett, or a topic such as tariffs. ↑ ↓ to move, Enter to open.